"Breast Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancer of the human BREAST.
Descriptor ID |
D001943
|
MeSH Number(s) |
C04.588.180 C17.800.090.500
|
Concept/Terms |
Breast Neoplasms- Breast Neoplasms
- Breast Neoplasm
- Neoplasm, Breast
- Breast Tumors
- Breast Tumor
- Tumor, Breast
- Tumors, Breast
- Neoplasms, Breast
Breast Carcinoma- Breast Carcinoma
- Breast Carcinomas
- Carcinoma, Breast
- Carcinomas, Breast
Mammary Neoplasms, Human- Mammary Neoplasms, Human
- Human Mammary Neoplasm
- Human Mammary Neoplasms
- Neoplasm, Human Mammary
- Neoplasms, Human Mammary
- Mammary Neoplasm, Human
Breast Cancer- Breast Cancer
- Cancer, Breast
- Mammary Cancer
- Cancer, Mammary
- Cancers, Mammary
- Mammary Cancers
- Malignant Neoplasm of Breast
- Breast Malignant Neoplasm
- Breast Malignant Neoplasms
- Malignant Tumor of Breast
- Breast Malignant Tumor
- Breast Malignant Tumors
- Cancer of Breast
- Cancer of the Breast
|
Below are MeSH descriptors whose meaning is more general than "Breast Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Breast Neoplasms".
This graph shows the total number of publications written about "Breast Neoplasms" by people in this website by year, and whether "Breast Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2005 | 1 | 0 | 1 |
2007 | 1 | 0 | 1 |
2011 | 1 | 0 | 1 |
2012 | 2 | 0 | 2 |
2013 | 3 | 1 | 4 |
2014 | 5 | 0 | 5 |
2015 | 8 | 1 | 9 |
2016 | 6 | 3 | 9 |
2017 | 8 | 0 | 8 |
2018 | 7 | 0 | 7 |
2019 | 4 | 0 | 4 |
2020 | 8 | 1 | 9 |
2021 | 3 | 1 | 4 |
2022 | 4 | 0 | 4 |
2023 | 13 | 0 | 13 |
2024 | 4 | 0 | 4 |
2025 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Breast Neoplasms" by people in Profiles.
-
Antitumor Activity and Biomarker Analysis for TROP2 Antibody-Drug Conjugate Datopotamab Deruxtecan in Patient-Derived Breast Cancer Xenograft Models. Clin Cancer Res. 2025 Feb 03; 31(3):573-587.
-
Analysis the Burden of Breast Cancer Among Adolescents and Young Adults Using the Global Burden of Disease 2021. Ann Surg Oncol. 2025 Mar; 32(3):2056-2069.
-
Insulin-like growth factor binding protein-6 modulates proliferative antagonism in response to progesterone in breast cancer. Front Endocrinol (Lausanne). 2024; 15:1450648.
-
Cyclin-dependent kinase 4/6 inhibitors and cardiotoxic events in breast cancer: A pharmacovigilance study based on the FAERS database. Int J Cancer. 2025 Apr 01; 156(7):1404-1418.
-
Differential chromatin accessibility and transcriptional dynamics define breast cancer subtypes and their lineages. Nat Cancer. 2024 Nov; 5(11):1713-1736.
-
Exosc9 Initiates SUMO-Dependent lncRNA TERRA Degradation to Impact Telomeric Integrity in Endocrine Therapy Insensitive Hormone Receptor-Positive Breast Cancer. Cells. 2023 10 20; 12(20).
-
Chimeric RNAs reveal putative neoantigen peptides for developing tumor vaccines for breast cancer. Front Immunol. 2023; 14:1188831.
-
Biomechanical effect of neurologic dance training (NDT) for breast cancer survivors with chemotherapy-induced neuropathy: study protocol for a randomized controlled trial and preliminary baseline data. Trials. 2023 Sep 01; 24(1):564.
-
Diagnosis of breast implant associated ?anaplastic large cell lymphoma by analysis of cytokines in peri-implant seromas. Am J Hematol. 2023 11; 98(11):E312-E314.
-
Adherence to oral endocrine therapy in racial/ethnic minority patients with low socioeconomic status before and during the COVID-19 pandemic. Int J Clin Pharm. 2023 Dec; 45(6):1396-1404.